Viewing Study NCT06354842



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06354842
Status: COMPLETED
Last Update Posted: 2024-04-09
First Post: 2024-04-03

Brief Title: Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease
Sponsor: Medical University of Vienna
Organization: Medical University of Vienna

Study Overview

Official Title: Application of Pilocarpine Iontophoresis in Patients With Chronic Kidney Disease a Feasibility Study
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: It has been shown that excretion of sodium and water through the skin in the form of sweat represents a regulatory mechanism of electrolyte- and fluid balance Since patients with chronic kidney disease CKD exhibit increased skin sodium content we investigated the feasibility of sweat testing as a novel experimental tool to a more complete assessment of fluid- and sodium homeostasis

In this cross-sectional feasibility study we applied pilocarpine iontophoresis to induce sweat testing in 58 patients across various stages of CKD including patients after kidney transplantation as well as a healthy control cohort n6 to investigate possible effects of CKD and transplantation status on sweat rate and sodium concentration Due to non-linear relationships we modeled our data using polynomial regression

Decline of kidney function showed a significant association with lower sweat rates adj R² 02278 F2 61 1029 p 0000141 Sweat sodium concentrations were increased in moderate CKD however this effect was lost in end stage renal disease adj R² 03701 F4 59 1026 p 2261e-06 We observed higher sweat weight in males compared to females

Diagnostic sweat analysis represents an innovative and promising noninvasive option for more thorough investigation of sodium- and fluid homeostasis in CKD patients Lower sweat rates and higher sweat sodium concentrations represent a unique feature of CKD patients with potential therapeutic implications
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None